14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £141.16 £183.01 Thursday, 8th Feb 2024 ERGO.L stock ended at £1,346.00. During the day the stock fluctuated 0% from a day low at £1,346.00 to a day high of £1,346.00.
90 days £141.16 £227.30
52 weeks £84.73 £227.30

Historical Entia Biosciences Inc prices

Date Open High Low Close Volume
Sep 01, 2023 £1,044.00 £1,066.06 £1,038.00 £1,052.00 51 264
Aug 31, 2023 £1,037.74 £1,070.00 £1,036.00 £1,046.00 28 030
Aug 30, 2023 £1,016.00 £1,016.00 £1,016.00 £1,016.00 0
Aug 29, 2023 £1,030.00 £1,050.00 £1,030.00 £1,030.00 25 469
Aug 25, 2023 £993.00 £1,020.00 £993.00 £1,016.00 44 389
Aug 24, 2023 £1,014.00 £1,014.00 £960.00 £1,002.00 37 775
Aug 23, 2023 £974.00 £993.12 £954.77 £985.00 38 917
Aug 22, 2023 £983.00 £985.45 £960.61 £971.00 129 971
Aug 21, 2023 £1,020.00 £1,022.00 £963.00 £975.00 37 481
Aug 18, 2023 £1,046.00 £1,051.00 £992.10 £1,012.00 86 660
Aug 17, 2023 £1,070.00 £1,091.84 £1,044.00 £1,044.00 26 999
Aug 16, 2023 £1,100.00 £1,120.00 £1,066.00 £1,066.00 95 735
Aug 15, 2023 £1,112.00 £1,120.38 £1,100.00 £1,110.00 39 018
Aug 14, 2023 £1,106.00 £1,122.00 £1,102.22 £1,112.00 71 299
Aug 11, 2023 £1,110.00 £1,111.41 £1,086.00 £1,102.00 77 675
Aug 10, 2023 £1,106.00 £1,118.00 £1,100.00 £1,114.00 12 950
Aug 09, 2023 £1,096.00 £1,100.55 £1,088.00 £1,100.00 219 796
Aug 08, 2023 £1,094.00 £1,100.00 £1,084.00 £1,088.00 29 439
Aug 07, 2023 £1,098.00 £1,098.00 £1,084.00 £1,084.00 44 746
Aug 04, 2023 £1,098.00 £1,104.00 £1,086.00 £1,088.00 22 198
Aug 03, 2023 £1,062.00 £1,122.00 £1,062.00 £1,086.00 64 782
Aug 02, 2023 £1,092.00 £1,096.20 £1,084.00 £1,084.00 12 052
Aug 01, 2023 £1,120.00 £1,124.00 £1,086.00 £1,094.00 84 893
Jul 31, 2023 £1,086.00 £1,107.90 £1,084.00 £1,086.00 23 263
Jul 28, 2023 £1,102.00 £1,118.00 £1,090.00 £1,098.00 129 411
Click to get the best stock tips daily for free!

About Entia Biosciences Inc

Entia Biosciences Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance service... ERGO.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT